Newsroom

Mark Terry January 10, 2022 https://www.biospace.com/article/-clinical-catch-up-january-3-7 The biopharma industry has started 2022 with...

Heather McKenzie January 10, 2022 https://www.biospace.com/article/executive-perspectives-on-2022-/ After a decade of breakthroughs in...

By Sara Karlovitch OQL011, for cancer therapy induced skin toxicity, demonstrated a tolerable safety and acceptable efficacy profile,...

David E. Williams November 11, 2021 Hong Tang grew up in rural China, and was encouraged by her pharmacist sister to become a physician....

Moira Gunn November 9 On this week’s Tech Nation, Moira speaks with Dr. Sidarta Ribeiro, Deputy Director of the Brain Institute at the...

To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and...

In contrast to the innovations in cancer treatments that help drive improved survival, there are far fewer innovations targeting...

Link to Episode: http://thebioreport.com/2021/07/22/targeting-cancer-drug-side-effects-at-their-source/ While great strides have been...

Episode link: https://www.reorientpodcast.com/episodes/hong-tang Dr. Hong Tang is the Chief Medical Officer and co-founder of OnQuality...